Copyright
©The Author(s) 2021.
World J Hepatol. Mar 27, 2021; 13(3): 300-314
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.300
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.300
Table 1 Assessment of risk factors, clinical markers and investigations for lymphatic dysfunction in cirrhosis
Parameters | Findings that support or indicate lymphatic dysfunction |
Risk factors | (1) Old age; (2) metabolic syndrome (obesity, diabetes, dyslipidemia); and (3) concomitant inflammatory disorders |
Clinical examination | (1) Diuretic-resistant ascites; (2) severe generalised edema, scrotal/penile swelling; (3) lymphedema: Peau-d’orange appearance and a positive stemmer sign; (4) frequent cellulitis/lymphangitis of affected limbs; and (5) hyperkeratotic skin lesions, yellow nail |
Blood investigations | (1) Hypoproteinaemia and hypoalbuminemia; (2) lymphocytopenia; and (3) hypogammaglobulinemia |
Ascitic fluid analysis | Chylous ascites: Milky appearance, fluid triglyceride level ≥ 110mg/dL |
Upper endoscopy | Intestinal lymphangiectasia: Whitish congested villi in duodenum |
Radiological imaging: (lymphography, lymphoscintigraphy) | Abnormal lymphatic structure and/or lymph flow dynamics: Dilated lymphatic vessels, lymph stasis, lymph leakage |
Histopathological examination (liver/intestine) | (1) Increase in number and size of lymphatic structures; and (2) specific lymphatic endothelial markers for accurate identification: Prox-1, podoplanin, LYVE-1 |
- Citation: Kumar R, Anand U, Priyadarshi RN. Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications. World J Hepatol 2021; 13(3): 300-314
- URL: https://www.wjgnet.com/1948-5182/full/v13/i3/300.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i3.300